In both in vitro and in vivo studies, the ES2 peptide has shown potent senolytic activity with minimal apoptotic effects on non-senescent cancer cells [128]
GLOW is a powerful peptide injection therapy that combines: BPC-157 (5mg) a gastric-derived peptide that promotes tissue healing TB-500 (10mg) a synthetic form of thymosin beta-4 that regulates inflammation and cellular repair GHK-Cu (27mg) a copper-binding peptide that stimulates collagen, elastin, and wound healing This unique combination delivers full-spectrum regenerative support, from the inside outtargeting muscle, tendon, skin, fascia, and even blood vessels
Renukuntla, J., et al
1 Introduction Autoimmune diseases (ADs) arise from the immune systems aberrant response against self-tissues, encompassing diverse conditions such as rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), inflammatory bowel disease (IBD), type 1 diabetes (T1D), and primary biliary cholangitis (PBC) ( Mounting evidence suggests that gut microbiota and its metabolites play a key role in host health and diverse diseases, such as obesity, depression, sclerosis, kidney disease, and dialysis ( At present, in the interest of reshaping the disordered intestinal immune activity in the disease state and alleviating the disease, people propose a series of flora-related immunotherapies based on the close interaction between the intestinal immune system and the flora ( Clostridium , a genus of anaerobic, Gram-positive, thick-walled bacteria, constitutes a dominant component of the healthy gut microbiota ( Clostridium species may confer clinical benefits across multiple ADs ( 2 Classification and sources of Clostridium as probiotics The intestinal clostridia as probiotics mainly contain Clostridium butyricum ( CB ), Faecalibacterium prausnitzii ( FP ), Clostridium cocleatum , etc
Pharmacologic approaches to glycemic treatment: standards of care in diabetes-2025
